These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2976947)

  • 41. Platelet serotonin measures in primary dysthymia.
    Ravindran AV; Chudzik J; Bialik RJ; Lapierre YD; Hrdina PD
    Am J Psychiatry; 1994 Sep; 151(9):1369-71. PubMed ID: 8067494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
    Mellerup ET; Plenge P
    Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet 3H-imipramine and 3H-paroxetine binding during treatment with psychoactive drugs.
    Mellerup ET; Dam H; Lauritzen L; Plenge P
    Biol Psychiatry; 1991 Nov; 30(10):1056-8. PubMed ID: 1836743
    [No Abstract]   [Full Text] [Related]  

  • 44. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
    Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
    Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [3H]paroxetine binding in human platelets in relation to age and sex.
    Andersson A; Marcusson J
    Neurobiol Aging; 1990; 11(6):615-8. PubMed ID: 2149169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
    Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
    Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
    Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
    Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs].
    Katasonov AB; Beliaev BS; Zlobina GP; Faktor MI; Brusov OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):125-8. PubMed ID: 2728713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.
    Plenge P; Mellerup ET
    Biochim Biophys Acta; 1984 Feb; 770(1):22-8. PubMed ID: 6230106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
    Tasker TC; Kaye CM; Zussman BD; Link CG
    Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
    [No Abstract]   [Full Text] [Related]  

  • 53. Platelet serotonin in essential hypertension and in mental depression.
    Baudouin-Legros M; Le Quan-Bui KH; Guicheney P; Kamal LA; Meyer P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S12-4. PubMed ID: 2412030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3H-imipramine binding to freshly prepared platelet membranes in depression.
    Theodorou AE; Katona CL; Davies SL; Hale AS; Kerry SM; Horton RW; Kelly JS; Paykel ES
    Psychiatry Res; 1989 Jul; 29(1):87-103. PubMed ID: 2549556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls.
    Wägner A; Aberg-Wistedt A; Asberg M; Ekqvist B; Mårtensson B; Montero D
    Psychiatry Res; 1985 Oct; 16(2):131-9. PubMed ID: 3865253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.
    Suranyi-Cadotte BE; Quirion R; Nair NP; Lafaille F; Schwartz G
    Life Sci; 1985 Feb; 36(8):795-9. PubMed ID: 3974410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethanol intake and 3H-serotonin uptake. II: A study in alcoholic patients using platelets 3H-paroxetine binding.
    Daoust M; Lhuintre JP; Ernouf D; Legrand E; Breton P; Boucly P
    Life Sci; 1991; 48(20):1977-83. PubMed ID: 1827171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 59. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
    Malison RT; Price LH; Berman R; van Dyck CH; Pelton GH; Carpenter L; Sanacora G; Owens MJ; Nemeroff CB; Rajeevan N; Baldwin RM; Seibyl JP; Innis RB; Charney DS
    Biol Psychiatry; 1998 Dec; 44(11):1090-8. PubMed ID: 9836013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of membrane protein concentration on binding of 3H-imipramine in human platelets.
    Barkai AI; Kowalik S; Baron M
    Biol Psychiatry; 1985 Feb; 20(2):215-9. PubMed ID: 3971002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.